Barry S. Horowitz
US$ 29.75
ghk-cu 100mg fast shipping – Research Peptide GHK-Cu Copper Tripeptide-1 Peptide –
Description
Advances in Gerontology, 1 , 240-243
Safety Profile and Realistic Risk Assessment GHK-Cu demonstrates a generally favorable safety profile based on over 40 years of research, though most safety data derives from topical applications and animal studies
No results after three months Three months of consistent use should produce at least subtle improvements for most responders
One reconstituted EGRIFTA WR vial provides daily doses for 7 consecutive days
